Literature DB >> 15504443

Analyzing prescription drugs as causes of death on death certificates..

Diane K Wysowski, Parivash Nourjah.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15504443      PMCID： PMC1497672          DOI： 10.1016/j.phr.2004.09.001

Source DB:  PubMed          Journal:  Public Health Rep        ISSN： 0033-3549            Impact factor:   2.792


× No keyword cloud information.
  6 in total

1.  Using multiple cause-of-death data to improve surveillance of drug-related mortality.

Authors:  David L Nordstrom; Mieko L Yokoi-Shelton; Amy Zosel
Journal:  J Public Health Manag Pract       Date:  2013 Sep-Oct

Review 2.  Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines.

Authors:  Marina A Dobrovolskaia; Scott E McNeil
Journal:  J Control Release       Date:  2013-06-03       Impact factor: 9.776

3.  Using medical examiner case narratives to improve opioid overdose surveillance.

Authors:  Emily Hurstak; Christopher Rowe; Caitlin Turner; Emily Behar; Rachel Cabugao; Nikolas P Lemos; Catherine Burke; Phillip Coffin
Journal:  Int J Drug Policy       Date:  2018-01-30

4.  Surveillance of prescription drug-related mortality using death certificate data.

Authors:  Diane K Wysowski
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 5.  Pre-clinical immunotoxicity studies of nanotechnology-formulated drugs: Challenges, considerations and strategy.

Authors:  Marina A Dobrovolskaia
Journal:  J Control Release       Date:  2015-09-05       Impact factor: 9.776

Review 6.  ICD-10 codes used to identify adverse drug events in administrative data: a systematic review.

Authors:  Corinne M Hohl; Andrei Karpov; Lisa Reddekopp; Mimi Doyle-Waters; Jürgen Stausberg
Journal:  J Am Med Inform Assoc       Date:  2013-11-12       Impact factor: 4.497
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.